Value of Fetal Scalp Lactate Sampling During Labour in Cases of Abnormal Fetal Heart Rate

Value of Fetal Scalp Lactate Sampling During Labour in Cases of Abnormal Fetal Heart Rate During Labor Over 60 Minutes Without a Significant ST-event

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05259202

Enrollment

100

Registered

2022-02-28

Start date

2022-02-01

Completion date

2022-10-31

Last updated

2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Acidosis

Keywords

serious metabolic acidosis, T segment analysis, Blood samples, instrumental delivery, Apgar score, admission to a neonatal ward

Brief summary

ST-analysis of the foetal ECG (STAN®) is another second line technique for intrapartum foetal monitoring. Combining ST-analysis with standard CTG interpretation aims to identify hypoxic foetuses more accurately than CTG alone. The STAN® method identifies changes in the ST-interval of the foetal ECG that occur in the presence of foetalcentral hypoxia The aim of this studie is to investigate if the foetal lactate blood sampling is still useful when STAN® monitoring is already being used as a second line technique for intrapartum foetal monitoring if the fetal heart rate is abnormal without a significant ST event Nowadays in the Montpellier hospital's protocol, the investigators have to check the value of lactate sampling in case of le STAN doesn't detect an ST event. So this studie can change the Montpellier hospital's protocol and avoid useless fetal blood sampling

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patient with labor monitoring by ST segment analysis (STAN) according to current guidelines * patient who received a fetal lactate sample for fetal heart rate classified as pathological for more than 60 minutes

Exclusion criteria

* STAN guidelines not respected before installation and during work * misclassification of fetal heart rate * obstetrical complications during labor

Design outcomes

Primary

Measure	Time frame	Description
the incidence of serious metabolic acidosis	day 1	the incidence of serious metabolic acidosis (defined as pH \< 7 and Bdecf \> 12 mmol/L in the umbilical cord artery).

Secondary

Measure	Time frame	Description
Number of the instrumental delivery	day 1	Apgar score
Number of the neonatal outcome	day 1	admission to a neonatal ward

Countries

France

Contacts

Primary ContactWALTZING Aude, Resident

a-waltzingrenault@chu-montpellier.fr663801641

Backup ContactDUPORT-PERCIER Marie, MD

Outcome results